Metraipolis › archive › dc_ebf3ba7d81cc

Development of the Gutti Score: A Universal Clinical Assessment Framework for Patients Receiving Gabapentinoids, Opioids, Benzodiazepines, and Other Central… — Europe PMC PMID:42338831

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42338831
DOI
10.7759/cureus.109507
License (as archived)
solo-consultazione
Archived
2026-11-01T09:39:26.286Z
SHA-256 of the archived text
41082fc661ec1d4ceb085021b188029fe59721c56b5c8ca7d50349f12ef25396
Stable URL of this page
https://metraipolis.com/documento/dc_ebf3ba7d81cc

How to cite

Development of the Gutti Score: A Universal Clinical Assessment Framework for Patients Receiving Gabapentinoids, Opioids, Benzodiazepines, and Other Central… — Europe PMC PMID:42338831 — Europe PMC (en), https://europepmc.org/article/MED/42338831 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ebf3ba7d81cc (Metraipolis archive dc_ebf3ba7d81cc, sha256 41082fc661ec1d4ceb085021b188029fe59721c56b5c8ca7d50349f12ef25396)
BibTeX
@misc{dcebf3ba7d81cc,
  title = {Development of the Gutti Score: A Universal Clinical Assessment Framework for Patients Receiving Gabapentinoids, Opioids, Benzodiazepines, and Other Central… — Europe PMC PMID:42338831},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42338831},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ebf3ba7d81cc; sha256 41082fc661ec1d4ceb085021b188029fe59721c56b5c8ca7d50349f12ef25396},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42338831. Agents can read the archived copy with the MCP tool read_document.